Zeynep Eroglu, MD, explains the rationale for adding navitoclax to dabrafenib plus trametinib in the treatment of patients with BRAF V600–mutant metastatic melanoma, highlights the methodologies and results of the CTEP-P9466 trial, and describes the implications of this research for this patient population.
Andrew Koutnik Sansum Diabetes Research Institute (SDRI) has appointed Andrew Koutnik as a research scientist. Koutnik brings knowledge and expertise in
Jeff Vinik leaves and The Claw closes tampabay.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tampabay.com Daily Mail and Mail on Sunday newspapers.
Jeff Vinik leaving firm that developed Tampa's bustling Water Street tampabay.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tampabay.com Daily Mail and Mail on Sunday newspapers.